| No.8 Jinshun Road Zhuqiao Pudong New District,Shanghai,China | manager@passiondevelop.com |
 |
| Place of Origin: | China |
| Brand Name: | FILTER |
| Certification: | GMP |
| Model Number: | API |
| Minimum Order Quantity: | 10 vials |
|---|---|
| Packaging Details: | Plastic ,bubble, silver paper, 1kg/bag, 100g/bag |
| Delivery Time: | Within 7 working days |
| Payment Terms: | L/C, T/T, , MoneyGram,Alipay |
| Supply Ability: | 100000vials/month |
| Name: | Pen GH | Purity: | 99% |
|---|---|---|---|
| Specification: | 10iu/vial,36iu/vial | LimitNum: | 10 Vials |
| Storage: | Dry, Dark And Ventilated Place | DeliveryTime: | Within 7 Working Days |
| High Light: | peptides for muscle growth,injectable human growth hormone |
||
Injection Pen GH 36iu for Muscle Building with GMP From Lab (OEM)
Product Name:double chamber cartridge (OEM)
Specification:10IU,16IU,27IU,36IU
Packing:We are for OEM for clients who have Brands requiremtnts.
Our company Specialize in Peptides and Steriods.We have powder to control the quality
Let's us introduce more of us to you before Ordering:
double chamber cartridge:Most of our Bodybuilder Clients prefer this one.Different Price Based on Different Quantity,Except Giant Quantity.
Blood Test:It could Over 20 and some clients get the Result over 36.(Different Person differnt Result,but we could gurante over 20.)
La hormona del crecimiento (GH) es una pequeña proteína que es producida por la glándula pituitaria y secretada al torrente sanguíneo. La producción de GH está controlada por un conjunto complejo de hormonas producidas en el hipotálamo del cerebro y en el tracto intestinal y el páncreas.
La pituitaria saca GH en ráfagas; los niveles aumentan después del ejercicio, el trauma y el sueño. En condiciones normales, se produce más GH por la noche que durante el día. Esta fisiología es compleja, pero como mínimo, nos dice que los análisis de sangre esporádicos para medir los niveles de GH no tienen sentido ya que los niveles altos y bajos se alternan durante todo el día. Pero los científicos que miden cuidadosamente la producción general de GH informan que aumenta durante la infancia, alcanza su punto máximo durante la pubertad y disminuye a partir de la mediana edad.
La GH actúa en muchos tejidos de todo el cuerpo. En niños y adolescentes, estimula el crecimiento de hueso y cartílago. En personas de todas las edades, la GH aumenta la producción de proteínas, promueve la utilización de grasas, interfiere con la acción de la insulina y aumenta los niveles de azúcar en la sangre. La GH también eleva los niveles de factor de crecimiento similar a la insulina-1 (IGF-1).
Servicio:
Indíquenos qué marcas necesita y qué cantidad desea promocionar. Podemos crear sus propias marcas.
Adult Growth Hormone Deficiency (GHD)
Either of two approaches to double chamber cartridge dosing may be followed: a non-weight based regimen or a weight based regimen.
Non-weight based — based on published consensus guidelines, a starting dose of approximately 0.2 mg/day (range, 0.15–0.30 mg/day) may be used without consideration of body weight. This dose can be increased gradually every 1–2 months by increments of approximately 0.1–0.2 mg/day, according to individual patient requirements based on the clinical response and serum insulin-like growth factor I (IGF-I) concentrations. The dose should be decreased as necessary on the basis of adverse events and/or serum IGF-I concentrations above the age- and gender-specific normal range. Maintenance dosages vary considerably from person to person, and between male and female patients.
Weight based — based on the dosing regimen used in the original adult GHD registration trials, the recommended dosage at the start of treatment is not more than 0.04 mg/kg/week. The dose may be increased according to individual patient requirements to not more than 0.08 mg/kg/week at 4–8 week intervals. Clinical response, side effects, and determination of age- and gender-adjusted serum IGF-I concentrations should be used as guidance in dose titration.
A lower starting dose and smaller dose increments should be considered for older patients, who are more prone to the adverse effects of somatropin than younger individuals. In addition, obese individuals are more likely to manifest adverse effects when treated with a weight-based regimen. In order to reach the defined treatment goal, estrogen-replete women may need higher doses than men. Oral estrogen administration may increase the dose requirements in women.
| Component | 5 mg/1.5 mL | 10 mg/1.5 mL | 15 mg/1.5 mL | 30 mg/3 mL |
| Somatropin | 5 mg | 10 mg | 15 mg | 30 mg |
| Histidine | 1 mg | 1 mg | 1.7 mg | 3.3 mg |
| Poloxamer 188 | 4.5 mg | 4.5 mg | 4.5 mg | 9 mg |
| Phenol | 4.5 mg | 4.5 mg | 4.5 mg | 9 mg |
| Mannitol | 60 mg | 60 mg | 58 mg | 117 mg |
| HCl/NaOH | as needed | as needed | as needed | as needed |
| Water for Injection | up to 1.5 mL | up to 1.5 mL | up to 1.5 mL | up to 3 mL |
Contact Person: Qin
